Clinical trials and information management support
Active Definitive Contract Awarded Last action
- Contract number
- 75N91021C00009
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $51,133,673
Award facts
- Opportunity
-
- Clinical Trials and Information Management Support (CTIMS) Pre-Solicitation · 75N91020R00037 · Posted Feb 25, 2020
- Clinical Trials and Information Management Support Award Notice · Posted Apr 14, 2021
- Clinical Trials and Information Management Support (CTIMS) Solicitation · Posted Aug 7, 2020
- Clinical Trials and Information Management Support (CTIMS) Pre-Solicitation · Posted Jul 14, 2020
- Contract value 55% obligated
-
- $54,415,311.17 Current, with exercised options
- $93,199,585.17 Potential, with all options
- Completion date 91% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$536,935 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $9,000,000 | |
| Supplemental Agreement for work within scope | $7,000,000 | |
| Change Order | $0 | |
| Exercise an Option | $2,200,000 | |
| Exercise an Option | $8,550,000 | |
| Funding Only Action | $650,000 | |
| Funding Only Action | $0 | |
| Exercise an Option | $7,957,286 | |
| Funding Only Action | $1,550,000 | |
| Exercise an Option | $6,900,669 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $1,455,019 | |
| Original award | $6,407,634 |
Show all 16
About this award
The National Cancer Institute awarded a $93.2 million definitive contract to The Emmes Company, LLC for clinical trials and information management support on June 1, 2021, with no set-aside. The contract carries a cost-plus-fixed-fee pricing structure and runs through May 31, 2027.
The originating pre-solicitation, posted February 25, 2020, sought capability statements to provide direct organizational and data support for clinical trials programs, acquisition and analysis of trial data, project management of trials, correlative studies, and scientific committee support. The requirement anticipated supporting over 200 clinical trials annually across a seven-year period. Place of performance is Rockville, MD.
Government invoicing under this contract grew substantially from $2 million across 19,518 hours in FY2021 to $35 million invoiced in FY2025, when 120 FTEs were deployed. Derived government-paid rates averaged $104.71 per hour in FY2021, rising to $120.44 per hour by FY2024. The prime self-performed all reported hours with no subcontractor support in FY2025. NAICS code 541611 applies, with a $15 million small business size standard.
Quick answers
Who was awarded contract 75N91021C00009?
75N91021C00009 was awarded to The Emmes Company, LLC by National Cancer Institute (National Institutes of Health) on June 1, 2021.
How much is contract 75N91021C00009 worth?
The government has obligated $51,133,673 on 75N91021C00009. Its current value, with exercised options, is $54,415,311. Its potential value, with all options, is $93,199,585.
Was contract 75N91021C00009 competed?
The extent of competition for 75N91021C00009 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award